Abstract
Rational design of next-generation therapeutics can be facilitated by high-resolution structures of drug targets bound to small-molecule inhibitors. However, application of structure-based methods to macromolecules refractory to crystallisation has been hampered by the often-limiting resolution and throughput of cryogenic electron microscopy (cryo-EM). Here, we use high-resolution cryo-EM to determine structures of the CDK-activating kinase, a master regulator of cell growth and division, in its free and nucleotide-bound states and in complex with 14 inhibitors at up to 1.8 Å resolution. Our structures provide detailed insight into inhibitor interactions and networks of water molecules in the active site of cyclin- dependent kinase 7. Our data support a previously proposed mechanism contributing to inhibitor selectivity, thereby providing the basis for rational design of next-generation therapeutics. Additionally, our results establish a methodological framework for the use of high-resolution cryo-EM in structure-based drug design.
Competing Interest Statement
A.K. and A.F.K are employees of Thermo Fisher Scientific, the manufacturer of the electron microscopes used in this study. S.A. is a named inventor on patents concerning CDK7 inhibitors, which have been licensed to Carrick Therapeutics, and he owns shares in Carrick Therapeutics. A.K.B. is an employee and shareholder of Carrick Therapeutics.
Footnotes
Errors in the author list and acknowledgments have been corrected.